Last Updated on June 1, 2026 by The Health Master
NPPA
Download NPPA notification No. S.O. 2680 (E) dt 27-05-2026, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 2680 (E) dt 27-05-2026.
The notification states as follows:
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
A table is given below the article
Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.
The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules, including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.
Latest on National Pharmaceutical Pricing Authority (NPPA) Latest notifications – DPCO / NPPA
NPPA updated price lists: Download
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
National List of Essential Medicines (NLEM)
NPPA fixed retail price of 42 formulations: April 2026
NPPA fixed retail price of 20 formulations: February 2026
NPPA fixed Ceiling price of 6 scheduled formulations: November 2025
NPPA fixed retail price of 28 formulations: November 2025
IPC Initiative to Boost Quality Standards for Blood and Blood Components
CDSCO grants powers to Joint Drug Controllers for key approvals
Govt Proposes New Rules to Debar Firms Submitting Fake Documents
Commissioner FSDA appointed as Compounding Authority: Karnataka
Haryana Mandates Strict Scrutiny on Risky Solvents: Arti Singh Rao
Drug alert: 112 drug samples declared as NSQ in September 2025
India’s New Live ONDLS Portal Tracks High-Risk Solvents
USFDA inspection with positive VAI to Dr Reddy’s Formulations facility
Drug recall: Glenmark recalls 26,928 packs of oral contraceptives
New Drugs, Medical Devices and Cosmetics Act soon
Table
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1 | Alginate Raft -Forming Oral Suspension | Each 5 ml contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.5 mg Calcium Carbonate IP 80 mg | 1 ml | M/s Akums Drugs & Pharmaceuticals Ltd./M/s Blue Cross Laboratories Pvt. Ltd. | 0.90 |
| 2 | Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Liquid | Each 5 ml contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.5 mg Calcium Carbonate IP 80 mg | 1 ml | M/s Stedman Pharmaceuticals Pvt. Ltd. | 0.95 |
| 3 | Atorvastatin and Fenofibrate Tablets | Each Film Coated Tablet Contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Fenofibrate IP 160 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Wellness Ltd. | 18.46 |
| 4 | Bilastine & Montelukast Tablets | Each Film Coated Bilayered Tablet Contains: Bilastine IP 40 mg Montelukast Sodium IP eq. to Montelukast 10 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./M/s Aristo Pharmaceuticals Pvt. Ltd. | 21.22 |
| 5 | Bisoprolol Fumarate and Amlodipine Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg | 1 Tablet | M/s Swiss Garnier Life Sciences/ M/s Ipca Laboratories Ltd. | 9.40 |
| 6 | Bisoprolol Fumarate and Amlodipine Tablets | Each Film Coated Tablet Contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg | 1 Tablet | M/s Swiss Garnier Life Sciences/ M/s Ipca Laboratories Ltd. | 7.31 |
| 7 | Calcium, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets | Each Film Coated Tablet Contains: Calcium Carbonate IP 1250 mg Eq. to Elemental Calcium 500 mg Vitamin D3 IP 2000 IU Mecobalamin IP (Methylcobalamin) 1500 mcg L-Methylfolate Calcium 1 mg Pyridoxal – 5 – Phosphate 20 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Sun Pharmaceutical Industries Ltd. | 19.78 |
| 8 | Cefpodoxime and Potassium Clavulanate Oral Suspension | Each Combipack Contains: 1.Cefpodoxime & Potassium Clavulanate Oral Suspension Each 5 ml of constituted suspension contains: Cefpodoxime Proxetil IP Eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 31.25 mg 2. Sterile Water for reconstitution (Pyrogen free) 30ml | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. | 3.65 |
| 9 | Cefpodoxime and Potassium Clavulanate Oral Suspension | Each Combipack Contains: 1. Cefpodoxime & Potassium Clavulanate Oral Suspension Each 5 ml of constituted suspension contains: Cefpodoxime Proxetil IP Eq. to Cefpodoxime 100mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 62.50 mg 2. Sterile Water for reconstitution (Pyrogen free) 30ml | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. | 5.74 |
| 10 | Vitamin D3 Oral Solution | Each 5 ml Contains: Cholecalciferol IP 60000 IU (In Nano Droplet Form) | 1 ml | M/s Tirupati Medicare Ltd./ M/s Intas Pharmaceuticals Ltd. | 14.91 |
| 11 | Cholecalciferol Oral Solution | Each 5ml contains: Cholecalciferol IP 60000 IU | 1 ml | M/s Pharma Synth Formulations Ltd. | 15.88 |
| 12 | Cilnidipine and Telmisartan Tablets | Each Film Coated Tablet Contains: Cilnidipine IP 20 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Alkem Laboratories Ltd. | 14.95 |
| 13 | Cilnidipine and Telmisartan Tablets | Each Film Coated Tablet Contains: Cilnidipine IP 10 mg Telmisartan IP 40 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 12.98 |
| 14 | Cilnidipine, Telmisartan & Metoprolol Succinate (ER) Tablets | Each Film Coated Tablet Contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As Extended Release) Cilnidipine IP 10 mg Telmisartan IP 40 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./M/s Alkem Wellness Ltd. | 11.83 |
| 15 | Cilnidipine, Telmisartan & Metoprolol Succinate (ER) Tablets | Each Film Coated Tablet Contains: Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As Extended Release) Cilnidipine IP 10 mg Telmisartan IP 40 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./M/s Alkem Wellness Ltd. | 14.80 |
| 16 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate, Capsaicin & Menthol Gel | Composition: Diclofenac Diethylamine IP 1.16% w/w (eq. to Diclofenac Sodium 1% w/w) Linseed Oil BP 3% w/w Methyl Salicylate IP 10% w/wCapsaicin USP 0.025% w/w Menthol IP 5% w/w Benzyl Alcohol IP 1% w/w (Preservative) | 1 gm | M/s Theon Pharmaceuticals Ltd./ M/s Jagsonpal Pharmaceuticals Ltd. | 3.31 |
| 17 | Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Serratiopeptidase IP 10 mg (As enteric coated granules Eq. 20000 Serratiopeptidase Units) | 1 Tablet | M/s Innova Captab Ltd./ M/s Dr. Reddys Laboratories Ltd. | 10.07 |
| 18 | Dicyclomine Hydrochloride & Diclofenac Sodium Injection | Each ml contains Dicyclomine Hydrochloride IP 10 mg Diclofenac Sodium IP 25 mg Benzyl Alcohol IP 4% v/v (as preservative) | 1 ml | M/s Nichepharm Lifesciences Pvt. Ltd./M/s Blue Cross Laboratories Pvt. Ltd. | 10.05 |
| 19 | Dicyclomine Hydrochloride & Diclofenac Sodium Injection | Each ml contains: Dicyclomine Hydrochloride IP 20 mg Diclofenac Sodium IP 50 mg | 1 ml | M/s Fast Pharma Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 30.58 |
| 20 | Empagliflozin, Sitagliptin and Metformin Hydrochloride Extended Release Tablets | Each film coated bilayer tablet contains: Empagliflozin 10 mg Metformin Hydrochloride (As Extended Release) IP 1000 mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s USV Pvt. Ltd. | 14.88 |
| 21 | Myo-Inositol, D-Chiro Inositol and Vitamin D3 Powder | Each 5g Sachet contains: Vitamin D3 (Stabilized form) 1000 IU Myo-Inositol IP 2000 mg D-Chiro Inositol 50mg | 1 gm | M/s Safetab Life Science/ M/s Mankind Pharma Ltd. | 9.52 |
| 22 | Norethisterone Acetate Controlled Release Tablets | Each Film Coated Controlled Release Tablet contains: Norethisterone Acetate BP 15 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./M/s Zorvia Healthcare Ltd. | 20.11 |
| 23 | Norethisterone Acetate Controlled Release Tablets | Each Film Coated Controlled Release Tablet contains: Norethisterone Acetate BP 10 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./M/s Zorvia Healthcare Ltd. | 18.40 |
| 24 | Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine Maleate IP 2mg | 1 Tablet | M/s East African (India) Overseas/ M/s Macleods Pharmaceuticals Ltd. | 5.15 |
| 25 | Sitagliptin, Glimepiride and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Alkem Wellness Ltd. | 11.91 |
| 26 | Sitagliptin, Glimepiride and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Alkem Wellness Ltd. | 10.39 |
| 27 | Teneligliptin and Dapagliflozin Tablets | Each Film Coated Tablet Contains: Teneligliptin Hydrobromide Hydrate IP Eq. to Teneligliptin 20 mg Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./M/s Alkem Wellness Ltd. | 10.17 |
| 28 | Trypsin-Chymotrypsin With Paracetamol and Aceclofenac Tablets | Each film coated tablet contains: 50,000 Armour Units Enzymatic Activity Supplied by a Purified Concentrate which has Specific Trypsin & Chymotrypsin Activity in a Ratio of Approximately Six to One (As enteric coated granules) Paracetamol IP 325 mg Aceclofenac IP 100 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s Troikaa Pharmaceuticals Ltd. | 13.02 |
| 29 | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Vildagliptin IP 50 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Ved Lifesavers (P) Ltd./ M/s Alkem Wellness Ltd. | 9.79 |
| 30 | Tacrolimus Prolonged Release Capsules | Each hard gelatin capsule contains: Tacrolimus IP 3 mg | 1 Capsule | M/s Zydus Lifesciences Ltd. | 127.00 |
